STOCK TITAN
  1. Home
  2. Sec-filings
  3. MVIS
  4. [Form 4] Microvision Inc Insider Trading Activity

[Form 4] Microvision Inc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Insider Sharma Sumit
Role CEO
Type Security Shares Price Value
Tax Withholding Common Stock 341,931 $1.3182 $451K
Grant/Award Restricted Stock Units 375,000 $0.00 --
Exercise Restricted Stock Units 375,000 $0.00 --
Exercise Restricted Stock Units 371,250 $0.00 --
Exercise Common Stock 375,000 $0.00 --
Exercise Common Stock 371,250 $0.00 --
Holdings After Transaction: Common Stock — 1,302,740 shares (Direct); Restricted Stock Units — 375,000 shares (Direct)
Footnotes (1)
  1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis. Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement. The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $1.2801 to $1.37, inclusive. Each RSU represents a contingent right to receive one share of MicroVision common stock. RSUs vested on July 24, 2025, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2024 Executive Bonus Plan. At vesting, converts into shares of common stock on a unit-for-share basis. On July 27, 2024, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on July 27, 2027, subject to the Reporting Person's continued employment with the Issuer on each vesting date.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Sharma Sumit
(Last) (First) (Middle)
18390 NE 68TH STREET
(Street)
REDMOND WA 98052
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 07/24/2025 M 375,000 A $0.00 1,273,421 D
Common Stock(1) 07/24/2025 M 371,250 A $0.00 1,644,671 D
Common Stock(2) 07/25/2025 F 341,931 D $1.3182(3) 1,302,740 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0.00(4) 07/24/2025 A 375,000 07/24/2025(5) 07/24/2025 Common stock 375,000 $0.00 375,000 D
Restricted Stock Units $0.00(6) 07/24/2025 M 375,000 07/24/2025(5) 07/24/2025 Common stock 375,000 $0.00 0 D
Restricted Stock Units $0.00(6) 07/24/2025 M 371,250 07/24/2025(7) 07/24/2025 Common stock 371,250 $0.00 0 D
Explanation of Responses:
1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
2. Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement.
3. The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $1.2801 to $1.37, inclusive.
4. Each RSU represents a contingent right to receive one share of MicroVision common stock.
5. RSUs vested on July 24, 2025, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2024 Executive Bonus Plan.
6. At vesting, converts into shares of common stock on a unit-for-share basis.
7. On July 27, 2024, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on July 27, 2027, subject to the Reporting Person's continued employment with the Issuer on each vesting date.
/s/ Drew G. Markham, as attorney-in-fact 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR